RESUMEN
Cellulite affects almost all women, and it is characterized by surface relief alterations, mainly located on the thighs and buttocks, and other areas. Whereas depressed lesions occur due to the presence of thick subcutaneous fibrous septa that pull the skin surface down, raised areas result from the projection of underlying fat to the skin surface. We support that the absence of cellulite can be defined as the ideal balance between the mechanical forces that act between the subcutaneous structures, such as fat and fibrous septa and muscles, and the overlying skin.
Asunto(s)
Celulitis , Tejido Adiposo , Nalgas , Celulitis/diagnóstico por imagen , Femenino , Humanos , Piel , Tejido Subcutáneo , MusloAsunto(s)
Elasticidad , Examen Físico/métodos , Fenómenos Fisiológicos de la Piel , Piel/patología , Femenino , Humanos , Pruebas Cutáneas , Adulto JovenAsunto(s)
Toxinas Botulínicas Tipo A/administración & dosificación , Técnicas Cosméticas , Cejas/anatomía & histología , Músculos Faciales/efectos de los fármacos , Fármacos Neuromusculares/administración & dosificación , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Cejas/diagnóstico por imagen , Músculos Faciales/inervación , Femenino , Humanos , Inyecciones Intramusculares , Persona de Mediana Edad , Retratamiento/métodos , Envejecimiento de la Piel/efectos de los fármacos , Factores de Tiempo , Resultado del TratamientoAsunto(s)
Celulosa/uso terapéutico , Técnicas Cosméticas , Rellenos Dérmicos/uso terapéutico , Ácido Láctico/uso terapéutico , Manitol/uso terapéutico , Envejecimiento de la Piel , Celulosa/farmacología , Colágeno/efectos de los fármacos , Rellenos Dérmicos/farmacología , Cara , Humanos , Ácido Láctico/farmacología , Manitol/farmacología , Persona de Mediana Edad , Satisfacción del Paciente , Envejecimiento de la Piel/efectos de los fármacosRESUMEN
Photography is an important tool in dermatology. Reproducing the settings of before photos after interventions allows more accurate evaluation of treatment outcomes. In this article, we describe standardized methods and tips to obtain photographs, both for clinical practice and research procedural dermatology, using common equipment. Standards for the studio, cameras, photographer, patients, and framing are presented in this article.
Asunto(s)
Dermatología/métodos , Fotograbar/métodos , Fotograbar/normas , Vigilancia de la Población/métodos , Enfermedades de la Piel/diagnóstico por imagen , Vestuario , Dermatología/instrumentación , Extremidades , Cara , Humanos , Iluminación , Cuello , Cooperación del Paciente , Sistemas de Identificación de Pacientes , Posicionamiento del Paciente , Fotograbar/instrumentación , TorsoRESUMEN
BACKGROUND: Postauricular skin is one of the potential donor sites for split-thickness skin grafts (STSGs). OBJECTIVE: To objectively quantify how postauricular donor sites heal after STSG harvesting. MATERIALS AND METHODS: A cohort of 39 Mohs micrographic surgery patients repaired with STSGs (total 41 surgical defects) was established. Scars resulting from postauricular donor site harvesting were objectively quantified by applying the Vancouver Scar Scale (VSS), in which healing of scars is ranked from 0 (best possible outcome) to 13 (worst possible outcome). RESULTS: Vancouver Scar Scale scores were 1.87 for sites followed for ≥6 months (n = 16), 3 for sites followed for 3 to 6 months (n = 7), and 1.61 for sites followed for 6 to 11 weeks (n = 18). Four patients developed mild hypertrophic scarring that resolved spontaneously or with intralesional triamcinolone injections at a concentration of 10 mg/mL. CONCLUSION: The postauricular skin is an excellent donor site for small-to-moderate sized STSGs (<10 cm). The donor sites healed well, as noted by the low scores on the VSS consistent with mild changes in erythema, pigmentation, and texture. The incidence of hypertrophic scarring was low and resolved with observation or treatment.
Asunto(s)
Neoplasias de Cabeza y Cuello/cirugía , Neoplasias Cutáneas/cirugía , Trasplante de Piel , Recolección de Tejidos y Órganos , Sitio Donante de Trasplante , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Cirugía de Mohs , Pigmentación , Trasplante de Piel/efectos adversos , Recolección de Tejidos y Órganos/efectos adversos , Torso , Cicatrización de HeridasRESUMEN
IMPORTANCE: This article provides new data on a controversial issue, the influence of doses on the diffusion characteristics of 2 botulinum toxins type A. OBJECTIVE To assess the fields of effect of abobotulinumtoxinA and onabotulinumtoxinA at the same labeled unit dose (1:1 U) comparing sweat gland and muscle activity. DESIGN, SETTING, AND PARTICIPANTS: A prospective, single-center, randomized, double-blind study was conducted at the Brazilian Center for Studies in Dermatology in Porto Alegre, Brazil. The participants included 19 women. INTERVENTIONS: Each patient received 2 U of abobotulinumtoxinA on one side of the forehead and 2 U of onabotulinumtoxinA on the other side. MAIN OUTCOMES AND MEASURES: Horizontal and vertical diameter and area of the fields of anhidrotic effect, the amplitude of evoked compound muscle action potentials, and the 4-point validated Wrinkle Severity Scale were assessed at 28 days. RESULTS: The horizontal and vertical diameters of the fields of effect and the areas were significantly larger for onabotulinumtoxinA than those obtained for abobotulinumtoxinA. There were no significant differences between the products in the Wrinkle Severity Scale scores and Evoked Compound Muscle Action Potentials. OnabotulinumtoxinA had significantly more diffusion than abobotulinumtoxinA when isovolumetric injections of the same labeled unit dose of the products were injected. CONCLUSIONS AND RELEVANCE Although many studies state that diffusion is product dependent and abobotulinumtoxinA diffuses more than onabotulinumtoxinA, findings from the present study confirm that diffusion is dose dependent and the more potent dose tested diffuses more. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01732809.
Asunto(s)
Toxinas Botulínicas Tipo A/farmacología , Fármacos Neuromusculares/farmacología , Envejecimiento de la Piel/efectos de los fármacos , Adulto , Toxinas Botulínicas Tipo A/administración & dosificación , Toxinas Botulínicas Tipo A/farmacocinética , Brasil , Técnicas Cosméticas , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Potenciales Evocados/efectos de los fármacos , Femenino , Frente , Humanos , Persona de Mediana Edad , Fármacos Neuromusculares/administración & dosificación , Fármacos Neuromusculares/farmacocinética , Glándulas Sudoríparas/efectos de los fármacos , Glándulas Sudoríparas/metabolismoAsunto(s)
Crioterapia/métodos , Dermatología/métodos , 2-Propanol , Crioterapia/economía , Dermatología/economía , Humanos , AguaRESUMEN
BACKGROUND: The determination of the action halos of botulinum toxin type A aids in targeting specific muscles and/or sweat glands, thereby preventing the occurrence of side effects. OBJECTIVES: The objective of this study was to compare the action halos of two commercial preparations of botulinum toxin type A, Dysport (Ipsen, Slough, UK) and BOTOX (Allergan, Irvine, CA). MATERIAL AND METHODS: Eighteen volunteers received applications of both products into randomized sides of the frontalis muscle. Equivalent doses of 5 U of Dysport and 2 U of BOTOX were injected using the same technique, in the same volume (0.02 mL), and at a controlled depth. Twenty-eight days later, clinical and photographic assessments were performed. RESULTS: All the areas around the injected points were regular, round, or slightly oval and showed similar effects in the muscles and sweat glands. No statistically significant differences were observed between the mean sizes of the diameters of the halos produced by the two products. CONCLUSION: Injections of Dysport and BOTOX at an equivalence ratio of 2.5:1 U, respectively, applied at the same volume and depth, using the same technique resulted in similar action halos with regard to muscular and sweat gland activity. Both products seem to be safe and very predictable.
Asunto(s)
Toxinas Botulínicas Tipo A/farmacología , Músculo Esquelético/efectos de los fármacos , Fármacos Neuromusculares/farmacología , Glándulas Sudoríparas/efectos de los fármacos , Toxinas Botulínicas Tipo A/administración & dosificación , Frente , Humanos , Fármacos Neuromusculares/administración & dosificación , Proyectos PilotoRESUMEN
Inguinal Hyperhidrosis (IH) is a focal and primary form of hyperhidrosis in which the individual has intense sweating in the inguinal region. It usually appears in adolescence, not later than the age of 25, in the most cases, and continues into adulthood. With a sample of 26 patients we described Inguinal Hyperhidrosis (IH). Fifty percent of the patients have a positive family history of this condition or other forms of focal or generalized hyperhidrosis, which suggests a familial pattern. Biopsies performed on the inguinal area in a patient with IH and control patient showed normal histology. Excessive perspiration in the inguinal area significantly affects the quality of life of the patients. It is an embarrassing condition that produces large wet stains on the clothes, therefore making daily activities difficult and compromising the emotional, professional and social life of the affected patients. The therapies commonly used for other forms of focal hyperhidrosis are not yet referred in the literature specifically for IH. Intradermal injections from botulinum toxin provide positive results for the patients and controls the sweating for 6 months or more. It is a simple, safe and effective treatment for this condition and the results significantly improve the quality of life of the affected individuals.
Asunto(s)
Hiperhidrosis , Toxinas Botulínicas Tipo A/administración & dosificación , Ingle , Humanos , Hiperhidrosis/diagnóstico , Hiperhidrosis/patología , Hiperhidrosis/fisiopatología , Hiperhidrosis/terapia , Inyecciones Intradérmicas , Fármacos Neuromusculares/administración & dosificaciónRESUMEN
Medical grade liquid injectable silicone can be used for soft tissue augmentation to correct and replace lost volumes of the subcutaneous tissue. It is potentially a permanent tissue augmentation agent and is the most effective filler for certain indications. This article presents the history, mechanism of action, indications and contraindications, technique, and the possible complications of silicone and their treatment.